REPATRIATION MEDICAL AUTHORITY
INSTRUMENT NO. 92 OF 2011
VETERANS’ ENTITLEMENTS ACT 1986
MILITARY REHABILITATION AND COMPENSATION ACT 2004
EXPLANATORY NOTES FOR TABLING
- The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(2) & (8) of the Veterans’ Entitlements Act 1986 (the VEA) Statement of Principles Instrument No. 92 of 2011.
2. This Instrument amends Statement of Principles Instrument No. 1 of 2008 concerning malignant neoplasm of the urethra by:
- Deleting existing factor 6(e) concerning 'therapeutic radiation';
- Rewording clauses 4 and 5;
- Deleting the headnotes to and clauses 6, 7 and 8;
- Re-numbering existing clauses as required to reflect theses changes; and
- Deleting the definition of 'a course of therapeutic radiation'.
3. This Instrument also specifies a date of effect for the amendment in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003.
4. Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to malignant neoplasm of the urethra in the Government Notices Gazette of 3 November 2010, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. No submissions were received for consideration by the Authority during the investigation.
5. On 7 April 2011, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instrument and the medical-scientific material considered by the Authority. This letter emphasised the deletion of a factor relating to ionising radiation. The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination. No submissions were received for consideration by the Authority.
6. The determining of this Instrument finalises the investigation in relation to malignant neoplasm of the urethra as advertised in the Government Notices Gazette of 3 November 2010.
7. A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA. Any such request must be made in writing to the Repatriation Medical Authority at the following address:
The Registrar
Repatriation Medical Authority Secretariat
GPO Box 1014
BRISBANE QLD 4001